FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.8755
-0.0308 (-3.40%)
At close: Jul 2, 2026, 4:00 PM EDT
0.8810
+0.0055 (0.63%)
After-hours: Jul 2, 2026, 7:13 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $4.73 million as of July 2, 2026. Its market cap has decreased by -84.01% in one year.
Market Cap
4.73M
Enterprise Value
5.72M
1-Year Change
-84.01%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $4.73M, a decrease of -99.50%. That is a compound annual growth rate of -88.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.73M | -68.40% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 5.47M |
| Processa Pharmaceuticals | 5.39M |
| Mustang Bio | 5.31M |
| Alaunos Therapeutics | 5.23M |
| Liminatus Pharma | 5.15M |
| CollPlant Biotechnologies | 4.91M |
| Creative Medical Technology Holdings | 4.69M |
| Evogene | 4.65M |